Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02886377 : The Correlation Between AQP-4 Ab and the Visual Function of Patients With Demyelinating ON at Onset
PhaseN/A
AgesMin: 18 Years Max: 80 Years
Eligibility
Inclusion Criteria:

- Optic neuritis patients

Exclusion Criteria:

- The presence of significant refractive errors (3D of spherical equivalent refraction
or 2D of astigmatism), intraocular pressure of 21 mmHg or higher, systemic conditions
that could affect the visual system, and a history of ocular trauma or concomitant
ocular diseases, including a history of media opacification, ocular pathologies
affecting the cornea, lens, retinal disease, glaucoma, or laser therapy. All patients
in the study groups had an episode of ON more than six months before the study
inclusion time point.
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02886377      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740